Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

LEU

Centrus Energy Corp Approved for NYSE Uplisting

Centrus Energy Corp. (NYSE American: LEU) has just announced a significant development * the company has been approved for uplisting to the New York Stock Exchange (NYSE) from the NYSE American. This move reflects the company's growth and the value it continues to deliver for shareholders. As a result of the uplisting, Centrus' common stock will cease trading on the NYSE American after market close on December 3, 2025, and will commence trading on the NYSE effective at the opening of trading on December 4, 2025, under the symbol “LEU”.

According to Todd Tinelli, the Chief Financial Officer of Centrus, the company believes this move will provide improved liquidity for its shareholders while enhancing its visibility to a broader investor base as it works to restore America’s ability to enrich uranium at a large scale.

Chris Taylor, NYSE Group Chief Development Officer, welcomed Centrus to the New York Stock Exchange, highlighting the company's efforts to re-establish large-scale U.S.-owned uranium enrichment capacity for commercial and national security needs. He emphasized that Centrus is poised to benefit from the enhanced visibility, liquidity, and long-term value that the NYSE offers.

Centrus Energy is a trusted American supplier of nuclear fuel and services for the nuclear power industry. Since 1998, the company has provided its utility customers with more than 1,850 reactor years of fuel, equivalent to more than 7 billion tons of coal. The company is pioneering the production of high-assay, low-enriched uranium and leading the effort to restore America’s uranium enrichment capabilities at scale to meet clean energy, energy security, and national security needs. Following these announcements, the company's shares moved 2.0%, and are now trading at a price of $259.30. For the full picture, make sure to review CENTRUS ENERGY CORP's 8-K report.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS